Menovo(SH:603538) Zheng Quan Zhi Xing·2025-08-26 16:35Core Viewpoint - The document outlines the information disclosure management system of Ningbo Meinuo Pharmaceutical Co., Ltd, emphasizing the importance of accurate, timely, and fair disclosure of information that may impact stock trading prices [1][2]. Group 1: Information Disclosure Management - The company establishes a system to regulate the information disclosure behavior of its board members and senior management, ensuring compliance with relevant laws and regulations [1]. - Information that may affect stock trading prices includes periodic reports, temporary announcements, financial summaries, and other significant matters that are prepared but not yet disclosed [1][2]. - The board of directors leads the information disclosure work, with the board secretary responsible for handling external information publication [1][2]. Group 2: Confidentiality and Insider Information - Board members and senior management are required to maintain confidentiality regarding undisclosed significant information and are prohibited from leaking such information before it is publicly disclosed [2][3]. - There are strict rules against insider trading and market manipulation, with board members and senior management not allowed to disclose any undisclosed periodic reports or temporary announcements [2][3]. - The company has established a system for insider information knowledge, ensuring that those privy to undisclosed information adhere to confidentiality obligations [2][3]. Group 3: Approval and Reporting Process - Any external documents that need to be published must be submitted to the securities affairs department for review and approval by the board secretary before release [2][3]. - The company must refuse to submit annual statistical reports from external units that lack legal basis, while ensuring that any legally required submissions are documented and approved [3][4]. - External units or individuals are prohibited from disclosing any undisclosed significant information obtained through legal reporting requirements [4][5]. Group 4: Compliance and Accountability - The company mandates strict adherence to the information disclosure management system by all departments and subsidiaries, holding them accountable for any violations that result in economic losses [5]. - Any individual or entity that uses undisclosed information for trading or advising others to trade in the company's securities may face legal consequences [5]. - The document stipulates that in cases of conflict between this system and applicable laws or regulations, the latter will take precedence [5].